The rationale for using hydroxycarbamide in the treatment of sickle cell disease

Eitemau Tebyg

• The rationale for using hydroxycarbamide in the treatment of sickle cell disease” (Haematologica 2011;96:488–491). Reply
  gan: Pollack, Simeon
  Cyhoeddwyd: (2011)
• Hydroxyurea (hydroxycarbamide) for sickle cell disease
  gan: Nevitt, Sarah J, et al.
  Cyhoeddwyd: (2017)
• Hydroxycarbamide and White Matter Integrity in Paediatric Sickle Cell Disease
  gan: Lance, Eboni I., et al.
  Cyhoeddwyd: (2019)
• Role of hydroxycarbamide in prevention of complications in patients with sickle cell disease
  gan: Wiles, NM, et al.
  Cyhoeddwyd: (2009)
• Oscillatory haematopoiesis in adults with sickle cell disease treated with hydroxycarbamide
  gan: Baird, John H., et al.
  Cyhoeddwyd: (2014)